• Metabolic Alterations in Posterior Fossa Malignancies: Beyon

  2026-04-28

  This article examines the doctoral study by Derek Dang, which advances our understanding of metabolic reprogramming in posterior fossa malignancies beyond the classical Warburg effect. The research leverages advanced molecular techniques to dissect complex metabolic shifts, providing new directions for targeted interventions and phosphoproteomic workflows.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-04-28

  The Hoechst 33342/PI Double Staining Kit enables precise discrimination of apoptotic, necrotic, and viable cells in fluorescence-based assays, supporting basic research workflows. It is not intended for diagnostic or medical use, and its protocol is optimized for microscopy-based cell death analysis.

• Septin4 Enhances VHL-Mediated HIF-1α Degradation in Cardiomy

  2026-04-27

  This study uncovers a novel mechanism by which Septin4 promotes cardiomyocyte apoptosis under hypoxic conditions, acting through enhancement of VHL-mediated HIF-1α degradation. The findings offer new insight into myocardial hypoxia injury and highlight potential molecular targets for therapeutic intervention.

• Y-27632 and the Science of Organoid Generation: A New Era in

  2026-04-27

  Explore how Y-27632, a selective ROCK inhibitor, is revolutionizing organoid generation and cytoskeletal dynamics modulation. This article unveils advanced, evidence-based strategies for cancer biology research, emphasizing practical assay decisions and protocol optimization.

• Demethyleneberberine: Translational Neuroprotection & Inflam

  2026-04-26

  Explore the multifaceted bioactivity of Demethyleneberberine (DMB), a natural isoquinoline alkaloid, as an advanced anti-inflammatory and neuroprotective agent. This article uniquely synthesizes mechanistic depth with practical assay guidance for researchers.

• GOT1 Inhibition by Ziprasidone Alters Redox Metabolism in PD

  2026-04-25

  Yang et al. (2022) identify ziprasidone as a non-competitive GOT1 inhibitor, disrupting glutamine metabolism and redox balance in pancreatic ductal adenocarcinoma (PDAC) cells. This study highlights a metabolic vulnerability in PDAC, offering new avenues for targeted intervention and mechanistic exploration in cancer metabolism.

• Anlotinib hydrochloride: Reliable Multi-Target TKI for Cance

  2026-04-24

  This article provides scenario-driven, evidence-based guidance for integrating Anlotinib hydrochloride (SKU C8688) into cell viability, proliferation, and angiogenesis research workflows. It addresses common experimental challenges and compares vendor options, grounding recommendations in validated quantitative data and protocol best practices.

• BMN 673 (Talazoparib): Protocols and Precision in DNA Repair

  2026-04-24

  BMN 673 (Talazoparib) sets the benchmark for selective PARP1/2 inhibition, offering researchers exceptional potency and specificity for DNA repair deficiency targeting. This article delivers actionable, protocol-level guidance for deploying BMN 673 in homologous recombination-deficient cancer models, with troubleshooting insights and a translational bridge to the latest mechanistic discoveries.

• Cefepime (BMY-28142): Reliable Research Solutions for Lab Ch

  2026-04-23

  This article addresses common laboratory challenges in cell viability and resistance assays, demonstrating how Cefepime (BMY-28142) (SKU BA1013) from APExBIO delivers reproducible, evidence-backed results. Scenario-based Q&A blocks guide biomedical researchers in optimizing protocols, interpreting data, and selecting reliable antibiotic standards for advanced bacterial infection and CNS models.

• NU6300 Blocks Gasdermin D Cleavage to Inhibit Pyroptosis

  2026-04-23

  Jiang et al. identify NU6300 as a covalent inhibitor of gasdermin D, blocking cleavage and palmitoylation at cysteine-191, and thereby suppressing pyroptotic cell death. This mechanism offers a new avenue for targeting inflammasome-driven inflammatory diseases, with implications for both mechanistic studies and translational research.

• Direct Mouse Genotyping Kit: Streamlined PCR from Mouse Tiss

  2026-04-22

  Accelerate and simplify your mouse genotyping workflow using the Direct Mouse Genotyping Kit. Its purification-free, rapid lysis and ready-to-use PCR master mix with dye enable high-throughput screening and reproducible results directly from mouse tissue—ideal for demanding biomedical research applications.

• Carbapenemase Genes in CREC: Transmission Dynamics in Guangd

  2026-04-22

  This study provides the first comprehensive characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during 2022–2024. It reveals high rates of CEG carriage, multidrug resistance, and plasmid-mediated horizontal transmission, with implications for infection control and resistance surveillance.

• Trifluoperazine 2HCl: Potent Dopamine D2 Receptor Inhibitor

  2026-04-21

  Trifluoperazine 2HCl is a high-affinity dopamine D2 receptor inhibitor with nanomolar potency, robust solubility, and reproducible effects in dopaminergic signaling pathway modulation. It supports advanced research in neuropharmacology, macrophage antibacterial mechanisms, and cancer biology with well-defined mechanistic benchmarks.

• Epinephrine Bitartrate: Optimized Workflows for Adrenergic R

  2026-04-21

  (-)-Epinephrine (+)-bitartrate from APExBIO stands out as a high-purity, non-selective adrenergic receptor agonist for precise modulation in cardiovascular, neurobiology, and sympathetic nervous system research. This guide translates advanced reference findings and real-world protocols into actionable workflows, troubleshooting advice, and comparative context for reliable adrenergic signaling pathway studies.

• PP2A-Regulated Autophagy Drives Candida albicans Drug Resist

  2026-04-20

  This study uncovers how protein phosphatase 2A (PP2A) modulates autophagy via ATG protein phosphorylation, thereby influencing both biofilm formation and antifungal drug resistance in Candida albicans. The findings suggest targeting PP2A-mediated autophagy as a new strategy to overcome biofilm-associated resistance, informing experimental antifungal workflows.

451 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page